(Corrects headline to Bayer, not BASF)
FRANKFURT, April 29 (Reuters) - Germany’s Bayer agreed to acquire U.S. birth-control devices company Conceptus for $1.1 billion in cash, to cement its position as the world’s largest women’s healthcare provider.
Within the next ten business days, Bayer will launch a public tender offer to acquire all shares in Conceptus for $31.00 apiece, with closing of the deal expected by mid-year 2013, Bayer said on Monday.
Conceptus had $28.2 million in adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) last year, on sales of $141 million.
Reporting by Ludwig Burger